Current Awareness on Comparative and Functional Genomics

2003. Special issue: Macromolecular crystallization in the structural genomics era. J Struct Biol 142: (1) 2003. Special issue: Symposium on Advances in Canine and Feline Genomics Comparative Genome Anatomy and Genetic Disease, St Louis, Missouri, USA, May 16-19, 2002. J Hered 94: (1) Altman RB. 2003. Genetic sequence data for pharmacogenomics. Curr Opin Drug Discov Dev 6: (3) 297. Baak JPA, Path FRC, Hermsen MAJA, Meijer G, Schmidt J, Janssen EAM. 2003. Genomics and proteomics in cancer (Review). Eur J Cancer 39: (9) 1199. Babbitt PC. 2003. Definitions of enzyme function for the structural genomics era. Curr Opin Chem Biol 7: (2) 230. Bastian BC. 2003. Understanding the progression of melanocytic neoplasia using genomic analysis: From fields to cancer. Oncogene 22: (20) 3081. Boag PR, Gasser RB, Nisbet AJ, Newton SE. 2003. Genomics of reproduction in parasitic nematodes: Fundamental and biotechnological implications (Review). Biotechnol Advan 21: (2) 103. Bogue CW. 2003. Functional genomics in the mouse: Powerful techniques for unraveling the basis of human development and disease (Review). J Appl Physiol 94: (6) 2502. Brey PT. 2003. Anopheles gambiae genome: Perspectives for malaria control. Mol Cells 15: (2) 133. Campbell DA, Szardenings AK. 2003. Functional profiling of the proteome with affinity labels. Curr Opin Chem Biol 7: (2) 296. Carlton J. 2003. Vivax series: The Plasmodium vivax genome sequencing project (Review). Trends Parasitol 19: (5) 227. Costa LG, Cole TB, Jarvik GP, Furlong CE. 2003. Functional genomics of the paraoxonase (PON1) polymorphisms: Effects on pesticide sensitivity cardiovascular disease, and drug metabolism. Annu Rev Med 54: 371. Denslow N, Michel ME, Temple MD, Hsu CY, Saatman K, Hayes RL. 2003. Application of proteomics technology to the field of neurotrauma. J Neurotrauma 20: (5) 401. Durand P, Medigue C, Morgat A, Vandenbrouck Y, Viari A, Rechenmann F. 2003. Integration of data and methods for genome analysis. Curr Opin Drug Discov Dev 6: (3) 346. Figeys D. 2003. Proteomics in 2002: A year of technical development and wide-ranging applications (Review). Anal Chem 75: (12) 2891. Freudenberg J. 2003. Genome-wide prediction of disease-relevant genes and variants. Curr Opin Drug Discov Dev 6: (3) 304. Golden JB. 2003. Prioritizing the human genome: Knowledge management for drug discovery. Curr Opin Drug Discov Dev 6: (3) 310. Grewal A, Stockton J, Bolger C. 2003. Tools for discovery: Gene expression enterprise solutions. Curr Opin Drug Discov Dev 6: (3) 333. Haley-Vicente D, Edwards DJ. 2003. Proteomic informatics: In silico methods lead to data management challenges. Curr Opin Drug Discov Dev 6: (3) 322. Hedges SB, Kumar S. 2003. Genomic clocks and evolutionary timescales (Review). Trends Genet 19: (4) 200. Hofmann G, McIntyre M, Nielsen J. 2003. Fungal genomics beyond Saccharomyces cerevisiae? Curr Opin Biotechnol 14: (2) 226. Huang Y, Sadee W. 2003. Drug sensitivity and resistance genes in cancer chemotherapy: A chemogenomics approach. Drug Discov Today 8: (8) 356. Huber LA, Pfaller K, Vietor I. 2003. Organelle proteomics: Implications for subcellular fractionation in proteomics (Review). Circ Res 92: (9) 962. Jechlinger M, Grunert S, Beug H. 2002. Mechanisms in epithelial plasticity and metastasis: Insights from 3D cultures and expression profiling. J Mammary Gland Biol Neoplasia 7: (4) 415. Lindpaintner K. 2003. Pharmacogenetics and pharmacogenomics in drug discovery and development: An overview. Clin Chem Lab Med 41: (4) 398. Liotta LA, Espina V, Mehta AI, Calvert V, Rosenblatt K, Geho D, Munson PJ, Young L, Wulfkuhle J, Petricoin EF. 2003. Protein microarrays: Meeting analytical challenges for clinical applications (Review). Cancer Cell 3: (4) 317. Lubec G, Krapfenbauer K, Fountoulakis M. 2003. Proteomics in brain research: Potentials and limitations (Review). Prog Neurobiol 69: (3) 193. Maithal K. 2002. Proteomics: A new player in the post-genomic era (Review). Indian J Biochem Biophys 39: (5) 291. Marnellos G. 2003. High-throughput SNP analysis for genetic association studies. Curr Opin Drug Discov Dev 6: (3) 317. Mitsiades CS, Mitsiades N, Treon SP, Anderson KC. 2003. Proteomic analyses in Waldenstrom’s macroglobulinemia and other plasma cell dyscrasias. Semin Oncol 30: (2) 156. Moggs JG, Orphanides G. 2003. Genomic analysis of stress response genes. Toxicol Lett 140-141: 149. Napoli C, Lerman LO, Sica V, Lerman A, Tajana G, De Nigris F. 2003. Microarray analysis: A novel research tool for cardiovascular scientists and physicians (Review). Heart 89: (6) 597. Noguchi Y, Sakai R, Kimura T. 2003. Metabolomics and its potential for assessment of adequacy and safety of amino acid intake. J Nutr 133: (Suppl 1) 2097S. O’Brien TP, Bult CJ, Cremer C, Grunze M, Knowles BB, Langowski J, McNally J, Pederson T, Politz JC, Pombo A et al. 2003. Genome function and nuclear architecture: From gene expression to nanoscience. Genome Res 13: (6) 1029. Ohno R, Nakamura Y. 2003. Prediction of response to imatinib by cDNA microarray analysis. Semin Hematol 40: (2) 42. Orphanides G. 2003. Toxicogenomics: Challenges and opportunities. Toxicol Lett 140-141: 145. Osterman A, Overbeek R. 2003. Missing genes in metabolic pathways: A comparative genomics approach. Curr Opin Chem Biol 7: (2) 238. Papin JA, Price ND, Wiback SJ, Fell DA, Palsson BO. 2003. Metabolic pathways in the post-genome era (Review). Trends Biochem Sci 28: (5) 250. Pennacchio LA, Rubin EM. 2003. Comparative genomic tools and databases: Providing insights into the human genome. J Clin Invest 111: (8) 1099. Petricoin EF, Paweletz CP, Liotta LA. 2002. Clinical applications of proteomics: Proteomic pattern diagnostics. J Mammary Gland Biol Neoplasia 7: (4) 433. Pickar D. 2003. Pharmacogenomics of psychiatric drug treatment (Review). Psychiatr Clin North Am 26: (2) 303. Powell FL. 2003. Functional genomics and the comparative physiology of hypoxia. Annu Rev Physiol 65: 203. Price ND, Papin JA, Schilling CH, Palsson BO. 2003. Genome-scale microbial in silico models: The constraints-based approach (Review). Trends Biotechnol 21: (4) 162. Prosser H, Rastan S. 2003. Manipulation of the mouse genome: A multiple impact resource for drug discovery and development (Review). Trends Biotechnol 21: (5) 224. Comparative and Functional Genomics Comp Funct Genom 2003; 4: 68I–688 Published online in Wiley InterScience (www.interscience.wiley.com). DOI: I0.I002/cfg.23I